Contributors |
|
ix | |
Preface |
|
xi | |
|
1 Protein intrinsic disorder and structure-function continuum |
|
|
1 | (18) |
|
|
|
2 | (1) |
|
2 Locks, keys, and protein functionality |
|
|
3 | (1) |
|
3 Intrinsic disorder, multifunctionality, and "moonlighting" vs. structure-function paradigm |
|
|
4 | (1) |
|
4 Proteoforms against "one gene-one enzyme" hypothesis |
|
|
5 | (1) |
|
5 Intrinsic disorder and proteoforms |
|
|
6 | (3) |
|
6 Proteoforms and structural flexibility of ordered proteins |
|
|
9 | (1) |
|
7 Proteoforms and protein-structure continuum |
|
|
10 | (1) |
|
|
11 | (8) |
|
2 Intrinsic disorder associated with 14-3-3 proteins and their partners |
|
|
19 | (44) |
|
|
|
|
20 | (1) |
|
2 Role of protein modules, intrinsic disorder, and posttranslational modifications in protein-protein recognition |
|
|
21 | (4) |
|
3 14-3-3 Protein hubs: General aspects |
|
|
25 | (2) |
|
4 Structural features and intrinsic disorder associated with 14-3-3 proteins |
|
|
27 | (6) |
|
5 Multifunctionality of 14-3-3 proteins |
|
|
33 | (3) |
|
6 Intrinsic disorder and the 14-3-3 interactome |
|
|
36 | (6) |
|
7 Protein-protein interaction subnetworks of 14-3-3 paralogs |
|
|
42 | (1) |
|
8 The mechanism of binding of intrinsically disordered target proteins to 14-3-3 |
|
|
43 | (5) |
|
9 Conclusions and perspectives |
|
|
48 | (1) |
|
|
49 | (1) |
|
|
49 | (14) |
|
3 Intrinsically disordered proteins and phenotypic switching: Implications in cancer |
|
|
63 | (22) |
|
|
|
|
64 | (1) |
|
2 Conformational noise hypothesis: The MRK model |
|
|
65 | (3) |
|
3 Evidence supporting the MRK hypothesis |
|
|
68 | (3) |
|
|
71 | (1) |
|
5 Inheritance of acquired learning |
|
|
72 | (3) |
|
6 Therapeutic implications |
|
|
75 | (1) |
|
|
76 | (1) |
|
|
76 | (8) |
|
|
84 | (1) |
|
4 Translational diffusion of unfolded and intrinsically disordered proteins |
|
|
85 | (24) |
|
|
|
|
|
|
86 | (1) |
|
|
87 | (8) |
|
|
95 | (6) |
|
4 Conclusions and future directions |
|
|
101 | (1) |
|
|
102 | (7) |
|
5 Intrinsically disordered proteins in the formation of functional amyloids from bacteria to humans |
|
|
109 | (36) |
|
|
|
|
|
1 An introduction to intrinsically disordered proteins |
|
|
110 | (2) |
|
2 Mechanism of protein aggregation and amyloid formation |
|
|
112 | (2) |
|
3 Supramolecular architecture of amyloids |
|
|
114 | (2) |
|
4 Amyloids as functional workhorses |
|
|
116 | (1) |
|
5 Bacterial functional amyloids |
|
|
117 | (5) |
|
6 Functional amyloids in yeast |
|
|
122 | (3) |
|
7 Functional amyloids in long-term memory in Aplysia and Drosophila |
|
|
125 | (1) |
|
8 Amyloid fibers in spider silk |
|
|
126 | (1) |
|
9 Functional amyloids in vertebrates and higher organisms |
|
|
126 | (1) |
|
10 Functional amyloids in mammals and humans |
|
|
127 | (6) |
|
11 Functional amyloids in the plant kingdom |
|
|
133 | (1) |
|
12 Conclusions and future directions |
|
|
133 | (1) |
|
|
134 | (1) |
|
|
134 | (11) |
|
6 Intrinsically disordered proteins in various hypotheses on the pathogenesis of Alzheimer's and Parkinson's diseases |
|
|
145 | (80) |
|
|
|
|
146 | (18) |
|
2 A brief summary of techniques currently used for in vivo, in vitro, and in silico AD and PD analysis |
|
|
164 | (10) |
|
3 Some insights from computational biology and computational chemistry |
|
|
174 | (34) |
|
4 Disorder and aggregation propensity analysis using bioinformatics |
|
|
208 | (4) |
|
|
212 | (1) |
|
|
212 | (13) |
|
7 Shear-induced amyloid formation of IDPs in the brain |
|
|
225 | (86) |
|
|
|
227 | (2) |
|
|
229 | (6) |
|
3 Aβ shear within the brain? |
|
|
235 | (3) |
|
4 Previous, current, and future research in sheared Aβ and amyloid monomers |
|
|
238 | (3) |
|
5 General properties of IDPs and their application to Aβ |
|
|
241 | (4) |
|
6 The free energy folding Aβ landscape |
|
|
245 | (2) |
|
7 Aβ aggregation, oligomer structures, and drug intervention |
|
|
247 | (1) |
|
8 Brain environmental effects: Aβ flow paths and possible shear events |
|
|
248 | (18) |
|
9 The role of shear energy: What does Aβ * really mean? |
|
|
266 | (6) |
|
10 Mechanisms for Aβ aggregation: Thermal vs. shear activation |
|
|
272 | (1) |
|
11 Proposed Alzheimer's disease model with shear included |
|
|
273 | (13) |
|
12 In vivo and in vitro experiments |
|
|
286 | (7) |
|
13 Other amyloid diseases and participants in AD |
|
|
293 | (1) |
|
14 The shear extremes: Concussion and traumatic brain injury |
|
|
293 | (1) |
|
15 Extrapolations to non-amyloid diseases? |
|
|
294 | (1) |
|
|
294 | (3) |
|
17 Suggested future directions in shear research |
|
|
297 | (8) |
|
|
305 | (1) |
|
|
306 | (5) |
|
8 Role of intrinsic disorder in muscle sarcomeres |
|
|
311 | (30) |
|
|
|
|
|
312 | (1) |
|
2 Myosin-binding protein C (MyBP-C) |
|
|
313 | (8) |
|
3 Proteins of tropomodulin family |
|
|
321 | (13) |
|
|
334 | (1) |
|
|
335 | (1) |
|
|
335 | (6) |
|
9 Computational prediction of functions of intrinsically disordered regions |
|
|
341 | (30) |
|
|
|
|
|
342 | (1) |
|
2 Functional annotations of intrinsically disordered regions |
|
|
343 | (5) |
|
3 Prediction of functions of intrinsically disordered regions |
|
|
348 | (9) |
|
|
357 | (3) |
|
5 Summary and prospective advances |
|
|
360 | (2) |
|
|
362 | (1) |
|
|
362 | (9) |
|
10 The dark proteome of cancer: Intrinsic disorderedness and functionality of HIF-1α along with its interacting proteins |
|
|
371 | (34) |
|
|
|
|
|
|
373 | (2) |
|
|
375 | (1) |
|
|
376 | (19) |
|
|
395 | (3) |
|
|
398 | (1) |
|
|
398 | (1) |
|
|
398 | (7) |
Index |
|
405 | |